-- 
Novo Nordisk Seeks Approval on Degludec, Degludecplus Insulins

-- B y   B e n   L i v e s e y
-- 
2011-09-26T20:13:19Z

-- http://www.bloomberg.com/news/2011-09-26/novo-nordisk-seeks-approval-on-degludec-degludecplus-insulins.html
Novo Nordisk A/S submitted to the
European Medicines Agency two marketing authorisation
applications for the approval of “ultralong acting” insulin
Degludec and the insulin combination analogue DegludecPlus, it
said in a statement.  To contact the editor responsible for this story:
Ben Livesey at 
 blivesey@bloomberg.net  